MedTrace Logo

Sporadic Degenerative Ataxia With Adult Onset: Natural History Study

NCT02701036 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-06-29

No results posted yet for this study

Summary

The key goals of SPORTAX-NHS is to compare the phenotype of multiple system atrophy of cerebellar type (MSA-C) and sporadic adult onset ataxia of unknown aetiology (SAOA) and to determine the rate of disease progression in both groups including determination of the factors that predict the development of MSA-C vs. SAOA, and at which time after onset of ataxia, a reliable distinction between both disorders is possible.

The planned study will also allow to collect blood samples and other biomaterials from patients with sporadic ataxia, which will be useful for future genetic and biomarker studies.

Conditions

  • Late Onset Sporadic Cerebellar Ataxia

Sponsors & Collaborators

  • German Center for Neurodegenerative Diseases (DZNE)

    collaborator OTHER

  • Ataxia Study Group

    lead OTHER

Principal Investigators

  • Thomas Klockgether, MD · Department of Neurology, Bonn, Germany

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Austria
  • Germany
  • Italy
  • Netherlands
  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02701036 on ClinicalTrials.gov